Works by Yan Lin


Results: 3930
    1
    2
    3
    4
    5
    6
    7

    Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma.

    Published in:
    2017
    By:
    • Baljevic, Muhamed;
    • Zaman, Shadia;
    • Baladandayuthapani, Veerabhadran;
    • Lin, Yan;
    • Partovi, Claudia;
    • Berkova, Zuzana;
    • Amini, Behrang;
    • Thomas, Sheeba;
    • Shah, Jatin;
    • Weber, Donna;
    • Fu, Min;
    • Cleeland, Charles;
    • Wang, Xin;
    • Stellrecht, Christine;
    • Davis, Richard;
    • Gandhi, Varsha;
    • Orlowski, Robert;
    • Lin, Yan Heather;
    • de Partovi, Claudia Morales;
    • Thomas, Sheeba K
    Publication type:
    journal article
    8
    9
    10

    Performance evaluation of a chemiluminescence microparticle immunoassay for CK-MB.

    Published in:
    2018
    By:
    • Lin, Zhi‐yuan;
    • Fang, Yi‐zhen;
    • Jin, Hong‐wei;
    • Lin, Hua‐yue;
    • Dai, Zhang;
    • Luo, Qing;
    • Li, Hong‐wei;
    • Lin, Yan‐ling;
    • Huang, Shui‐zhen;
    • Gao, Lei;
    • Xu, Fei‐hai;
    • Zhang, Zhong‐ying;
    • Lin, Zhi-Yuan;
    • Fang, Yi-Zhen;
    • Jin, Hong-Wei;
    • Lin, Hua-Yue;
    • Li, Hong-Wei;
    • Lin, Yan-Ling;
    • Huang, Shui-Zhen;
    • Xu, Fei-Hai
    Publication type:
    journal article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Breast Cancer Screening in Denmark.

    Published in:
    2017
    By:
    • Changjun Wang;
    • Yidong Zhou;
    • Feng Mao;
    • Yan Lin;
    • Qiang Sun;
    • Wang, Changjun;
    • Zhou, Yidong;
    • Mao, Feng;
    • Lin, Yan;
    • Sun, Qiang
    Publication type:
    journal article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50